Author

Gwang Ha Kim

RANDOMIZED CLINICAL TRIAL: EFFICACY AND SAFETY OF FEXUPRAZAN IN PATIENTS WITH ACUTE OR CHRONIC GASTRITIS
RANDOMIZED CLINICAL TRIAL: EFFICACY AND SAFETY OF FEXUPRAZAN IN PATIENTS WITH ACUTE OR CHRONIC GASTRITIS

Gwang Ha Kim  et al.

RANDOMIZED CLINICAL TRIAL: EFFICACY AND SAFETY OF FEXUPRAZAN IN PATIENTS WITH ACUTE OR CHRONIC GASTRITIS
RANDOMIZED CLINICAL TRIAL: EFFICACY AND SAFETY OF FEXUPRAZAN IN PATIENTS WITH ACUTE OR CHRONIC GASTRITIS

RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASTAPRAZAN COMPARED WITH ESOMEPRAZOLE IN EROSIVE OESOPHAGITIS [ZASTAPRAZAN EROSIVE REFLUX OESOPHAGITIS-1 STUDY (ZERO-1)]
RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASTAPRAZAN COMPARED WITH ESOMEPRAZOLE IN EROSIVE OESOPHAGITIS [ZASTAPRAZAN EROSIVE REFLUX OESOPHAGITIS-1 STUDY (ZERO-1)]

Gwang Ha Kim  et al.

RANDOMISED CLINICAL TRIAL: COMPARISON OF TEGOPRAZAN AND LANSOPRAZOLE FOR THE MAINTENANCE THERAPY IN HEALED EROSIVE ESOPHAGITIS
RANDOMISED CLINICAL TRIAL: COMPARISON OF TEGOPRAZAN AND LANSOPRAZOLE FOR THE MAINTENANCE THERAPY IN HEALED EROSIVE ESOPHAGITIS

Gwang Ha Kim  et al.

Item 1 - 4 / 4
1